The Expert Network celebrates its newest member, Dr. Lawrence Marc Jacobson
New York, NY, August 10, 2016 (Newswire.com) - Dr. Lawrence Marc Jacobson, Board Certified Ophthalmologist, NYU Langone Medical Center, has joined The Expert Network, an invitation only service for distinguished professionals. Dr. Jacobson has been chosen as a Distinguished Doctor™ based on peer reviews and ratings, numerous recognitions, and accomplishments achieved throughout his career.
Dr. Jacobson outshines others in his field due to his extensive educational background, numerous awards and recognitions, and career longevity. He received his medical degree from Tufts University School of Medicine in Medford, Massachusetts in 1991. He went on to complete a residency in ophthalmology at the NYU Langone Medical Center where he now serves as a Clinical Assistant Professor in the Department of Ophthalmology. Dr. Jacobson is board certified by the American Board of Ophthalmology.
"There have been huge changes in ophthalmology over the last twenty years. I'm especially interested in a newer drug called Avastin. We have started using it in the treatment of a wide range of eye diseases, from proliferative diabetic retinopathy to neovascular glaucomas."
Lawrence Marc Jacobson, M.D., FACS, Board Certified Ophthalmologist, NYU Langone Medical Center
With over 20 years dedicated to medicine, Dr. Jacobson brings a wealth of knowledge to his industry, and in particular, to his area of expertise, ophthalmology. When asked why he decided to pursue a career in this specialization, Dr. Jacobson said:
"During my last two years of medical school one of my neighbors was an Ophthalmologist practicing at the Joslin Diabetes Center, also in Boston. And she asked me, ‘why aren't you looking at ophthalmology?’. I said ‘what's ophthalmology?’ I had no idea at the time. And so she invited me into her office and and she showed me some of the things that she did. She really seemed to enjoy the field because she got to meet all kinds of interesting people there. She told me that as an Ophthalmologist she was able to make her patients very happy, which was extremely rewarding for her. That’s what convinced me."
As a thought-leader in his specialty, Dr. Jacobson pays close attention to prevailing trends in ophthalmology. In particular, he is optimistic about the use of Avastin, an angiogenesis inhibitor – a drug designed to slow the growth of new blood vessels – now considered vital in treating certain eye diseases. He noted:
"There have been huge changes in ophthalmology over the last twenty years. I’m especially interested in a newer drug called Avastin. We have started using it in the treatment of a wide range of eye diseases, from proliferative diabetic retinopathy to neovascular glaucomas."
Dr. Jacobson is a Fellow of the American College of Surgeons, and a member of the The New York State Ophthalmology Society and the The American Academy of Ophthalmology. In addition to his practice at the NYU Langone Medical Center, he is also affiliated with the Lenox Hill Hospital and The New York Eye and Ear Infirmary.
For more information, visit Dr. Jacobson's profile on the Expert Network here: http://expertnetwork.co/members/lawrence-marc-jacobson,-md,-facs/2f5b01eb05b0921e
###
The Expert Network has written this news release with approval and/or contributions from Dr. Lawrence Marc Jacobson. The Expert Network is an invitation-only reputation management service that is dedicated to helping professionals stand out, network, and gain a competitive edge. The Expert Network selects a limited number of professionals based on their individual recognitions and history of personal excellence.
Source: The Expert Network
Share:
